R
Roberto Gotti
Researcher at University of Bologna
Publications - 146
Citations - 4777
Roberto Gotti is an academic researcher from University of Bologna. The author has contributed to research in topics: Capillary electrophoresis & Micellar electrokinetic chromatography. The author has an hindex of 31, co-authored 136 publications receiving 4095 citations.
Papers
More filters
Journal ArticleDOI
Gut microbiome of the Hadza hunter-gatherers
Stephanie L. Schnorr,Marco Candela,Simone Rampelli,Manuela Centanni,Clarissa Consolandi,Giulia Basaglia,Silvia Turroni,Elena Biagi,Clelia Peano,Marco Severgnini,Jessica Fiori,Roberto Gotti,Gianluca De Bellis,Donata Luiselli,Patrizia Brigidi,Audax Mabulla,Frank W. Marlowe,Amanda G. Henry,Alyssa N. Crittenden +18 more
TL;DR: It is shown that the Hadza have higher levels of microbial richness and biodiversity than Italian urban controls, and enrichment in Prevotella, Treponema and unclassified Bacteroidetes, as well as a peculiar arrangement of Clostridiales taxa, may enhance the hadza’s ability to digest and extract valuable nutrition from fibrous plant foods.
Journal ArticleDOI
Behçet's syndrome patients exhibit specific microbiome signature
Clarissa Consolandi,Silvia Turroni,Giacomo Emmi,Marco Severgnini,Jessica Fiori,Clelia Peano,Elena Biagi,Alessia Grassi,Simone Rampelli,Elena Silvestri,Manuela Centanni,Fabio Cianchi,Roberto Gotti,Lorenzo Emmi,Patrizia Brigidi,Nicola Bizzaro,Gianluca De Bellis,Domenico Prisco,Marco Candela,Mario Milco D'Elios +19 more
TL;DR: It is reported, for the first time, that a peculiar dysbiosis of the gut microbiota is present in patients with Behçet syndrome and this corresponds to specific changes in microbiome profile.
Journal ArticleDOI
Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC)
TL;DR: Reverse phase HPLC procedures (ODS column) were developed able to provide a single, symmetric peak for each drug and mixtures A-B, where A is 20 mM sodium heptansulphonate and B is acetonitrile-THF, proved to be suitable mobile phases to obtain selective separations of the cited ACE inhibitors.
Journal ArticleDOI
Oxalate consumption by lactobacilli : evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus
Silvia Turroni,Beatrice Vitali,Claudia Bendazzoli,Marco Candela,Roberto Gotti,Federica Federici,Franco Pirovano,Patrizia Brigidi +7 more
TL;DR: Evaluated the oxalate‐degrading activity in several Lactobacillus species widely used in probiotic dairy and pharmaceutical preparations to assess the possible contribution of LactOBacillus in regulating the intestinal oxalates homeostasis.
Journal ArticleDOI
Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT.
Elena Biagi,Daniele Zama,Claudia Nastasi,Clarissa Consolandi,Jessica Fiori,Simone Rampelli,Silvia Turroni,Manuela Centanni,Marco Severgnini,Clelia Peano,G. De Bellis,Giulia Basaglia,Roberto Gotti,Riccardo Masetti,Andrea Pession,Patrizia Brigidi,Marco Candela +16 more
TL;DR: The first longitudinal study to follow the gut microbiota trajectory, from both the phylogenetic and functional points of view, in pediatric patients undergoing HSCT, indicates that structure and temporal dynamics of the gut microbial ecosystem can be a relevant factor for the success of HSCT and opens the perspective to the manipulation of the pre-HSCT gut microbiota configuration to favor mutualistic persisters with immunomodulatory properties in the gut.